184) nificantly increased after noise exposure compared to control. |
185) er 14 hours after RT (3.8±0.3 ml/kg/min) compared to baseline (3.4±0.3 ml/kg/min), |
186) and 33±4 kcals/30 minutes, respectively) compared to baseline (30±3 kcal). |
187) l variations in liver and muscle glycogen compared to baseline levels were significa |
188) iminate NVC evoked by higher demand tasks compared to baseline or lower demand tasks |
189) tly improved immediately postintervention compared to baseline scores. |
190) , T50, T60, the T-Rec at T40, T50, T60, compared to the baseline. |
191) , the T-Oes and T-Rec at T40, T50, T60, compared to the baseline. |
192) Compared to their normal weight peers, ove |
193) complete the training (adaptation) phases compared to their 3xTg-AD (57.14%) counter |
194) od safety behavior and handling practices compared to their counterparts. |
195) S2), exhibiting inverted light-dependence compared to their extended analogs. |
196) Cers, exhibit increased cell permeability compared to their long-chain analogs as de |
197) nd frailty occurring at younger ages when compared to their non-Indigenous counterpa |
198) ce high rates of age-related illness when compared to their non-Indigenous counterpa |
199) Compared to control, polypharmacy reduced |
200) strategy was able to improve performance compared to control, and just NC, when com |
201) was not modulated by any cooling strategy compared to control, but NC has a chance t |
202) tified to be increased in human AD brains compared to control, including those invol |
203) tically significant improvement in ESS as compared to control, with no other signifi |
204) istically significant reductions in PaCO2 compared to control, with no significant i |
205) Compared to individuals homozygous for the |
206) Compared to individuals with no walking de |
207) akdown among the pain-related brain areas compared to individuals in MCS, pointing o |
208) th PAHD had 2.9° less peak hip extension compared to individuals in the Control gro |
209) OA) commonly walk with less hip extension compared to individuals without hip OA. |
210) uals with PAHD exhibit less hip extension compared to individuals without hip pain d |
211) s demonstrated clear signs of impaired CP compared to normal aging. |
212) ion-pulmonary arterial smooth muscle cell compared to normal cells. |
213) social cognition tasks in bvFTD detection compared to normal controls, as well as in |
214) ion-pulmonary arterial smooth muscle cell compared to normal pulmonary arterial smoo |
215) diopathic pulmonary arterial hypertension compared to normal subjects. |
216) ell lines at both mRNA and protein levels compared to normal tissue and control cell |
|